Paul Sekhri's Trading History
| VEEVVeeva Systems | Sep 03, 2026 | Director | Uninformative Buy | 128.45K | $4.80M | |
| APMDApnimed, Inc. | Aug 03, 2026 | Director | Informative Buy | 200.00K | $192.50K | |
| VTVTvTv Therapeutics | Nov 19, 2024 | Pres, CEO and Exec Chairperson, Director | Uninformative Buy | 83.78K | $120.75K | |
| HLSQTessera Defense and Homeland Security | Jul 30, 2021 | Director | Informative Buy | 50.00K | $1.95K | |
| ALBOAlbireo Pharma | ― | ― | ― | $0.00 | ||
| ~ARIAAriad | ― | ― | ― | $0.00 | ||
| ENUMQEnumeral Biomedical | ― | ― | ― | $0.00 | ||
| LBPHLongboard Pharmaceuticals | ― | ― | ― | ― | ||
| AXLAAxcella Health | ― | ― | ― | ― | ||
| ALPNAlpine Immune Sciences | ― | ― | ― | ― |
You May Also Like
Paul Sekhri insider profile FAQ
What is the percentage of profitable transactions made by Paul Sekhri?
The percentage of profitable transactions made by Paul Sekhri is 29%.
What is the average return per transaction made by Paul Sekhri?
The average return per transaction made by Paul Sekhri is -42.30%.
What stocks does Paul Sekhri hold?
Paul Sekhri holds: VEEV, ALPN, VTVT, AXLA, HLSQ, LBPH, APMD, ENUMQ, ~ARIA, ALBO stocks.
What was Paul Sekhri’s latest transaction?
Paul Sekhri’s latest transaction was an Uninformative Buy of $128.45K.
What was Paul Sekhri's most profitable transaction?
Paul Sekhri’s most profitable transaction was an Informative Sell of VEEV stock on June 21, 2021. The return on the trade was 39.80%.
What is Paul Sekhri's role in Veeva Systems?
Paul Sekhri's role in Veeva Systems is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.